285 related articles for article (PubMed ID: 7685262)
1. Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins.
Fox CC; Lichtenstein LM; Roche JK
Dig Dis Sci; 1993 Jun; 38(6):1105-12. PubMed ID: 7685262
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. III. Serum factor modulates circulating and mucosal mononuclear-cell reactivity to epithelial cell-associated components of colon (ECAC-C).
Dunkel G; Paul JW; Roche JK
J Clin Immunol; 1987 Mar; 7(2):159-73. PubMed ID: 3571435
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis.
Fox CC; Lazenby AJ; Moore WC; Yardley JH; Bayless TM; Lichtenstein LM
Gastroenterology; 1990 Jul; 99(1):119-24. PubMed ID: 1693122
[TBL] [Abstract][Full Text] [Related]
4. Histamine release from gut mast cells from patients with inflammatory bowel diseases.
Nolte H; Spjeldnaes N; Kruse A; Windelborg B
Gut; 1990 Jul; 31(7):791-4. PubMed ID: 1695160
[TBL] [Abstract][Full Text] [Related]
5. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease.
Crowe SE; Luthra GK; Perdue MH
Gut; 1997 Dec; 41(6):785-92. PubMed ID: 9462211
[TBL] [Abstract][Full Text] [Related]
6. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid.
Fox CC; Moore WC; Lichtenstein LM
Dig Dis Sci; 1991 Feb; 36(2):179-84. PubMed ID: 1703070
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro.
Roche JK; Fiocchi C; Youngman K
J Clin Invest; 1985 Feb; 75(2):522-30. PubMed ID: 3871793
[TBL] [Abstract][Full Text] [Related]
8. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls.
Bischoff SC; Schwengberg S; Wordelmann K; Weimann A; Raab R; Manns MP
Gut; 1996 Jan; 38(1):104-14. PubMed ID: 8566835
[TBL] [Abstract][Full Text] [Related]
9. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease.
Raithel M; Schneider HT; Hahn EG
Scand J Gastroenterol; 1999 May; 34(5):496-503. PubMed ID: 10423066
[TBL] [Abstract][Full Text] [Related]
10. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
11. Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue.
Bischoff SC; Lorentz A; Schwengberg S; Weier G; Raab R; Manns MP
Gut; 1999 May; 44(5):643-52. PubMed ID: 10205200
[TBL] [Abstract][Full Text] [Related]
12. Effect of colonoscopy premedication containing diazepam and pethidine on the release of mast cell mediators in gut mucosal samples.
Raithel M; Hochberger J; Hahn EG
Endoscopy; 1995 Aug; 27(6):415-23. PubMed ID: 8549437
[TBL] [Abstract][Full Text] [Related]
13. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
14. [Effect of tryptase inhibitors on histamine release from human colon mast cells].
Xie H; He SH; Cheng MH; Fu YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):678-81. PubMed ID: 15555433
[TBL] [Abstract][Full Text] [Related]
15. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy.
Raithel M; Matek M; Baenkler HW; Jorde W; Hahn EG
Int Arch Allergy Immunol; 1995 Oct; 108(2):127-33. PubMed ID: 7549499
[TBL] [Abstract][Full Text] [Related]
16. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
17. Functional abnormalities in the intestine associated with mucosal mast cell activation.
Crowe SE; Perdue MH
Reg Immunol; 1992; 4(2):113-7. PubMed ID: 1503888
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
Babyatsky MW; Rossiter G; Podolsky DK
Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
[TBL] [Abstract][Full Text] [Related]
19. Mast cells from human colonic mucosa and submucosa/muscle: a comparison with human lung mast cells.
Liu WL; Bosman L; Boulos PB; Lau HY; Pearce FL
Agents Actions; 1990 Apr; 30(1-2):70-3. PubMed ID: 1695465
[TBL] [Abstract][Full Text] [Related]
20. Sensitization to epithelial antigens in chronic mucosal inflammatory disease: immunochemical similarity of macromolecules in human colonic epithelium with murine intestinal epithelial cell-associated components (ECAC).
Paul JW; Kotz KW; Roche JK
Immunology; 1988 Dec; 65(4):551-7. PubMed ID: 2464542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
